首页> 外文OA文献 >Pretreatment neutrophil‐to‐lymphocyte ratio as a potential prognostic biomarker for newly diagnosed patients with metastatic castration‐sensitive prostate cancer

【2h】

Pretreatment neutrophil‐to‐lymphocyte ratio as a potential prognostic biomarker for newly diagnosed patients with metastatic castration‐sensitive prostate cancer

机译：预处理中性粒细胞至淋巴细胞比例作为新诊断患者转移性阉割敏感前列腺癌的潜在预后生物标志物

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Samer Salah; Ramiz Abu‐Hijlih; Fawzi Abuhijla; Faris Tamimi; Abdallah Al‐Tell; Mohammed Shahait;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials [J] . van Soest R. J., Templeton A. J., Vera-Badillo F. E., Annals of oncology: official journal of the European Society for Medical Oncology . 2015,第4期

机译：中性粒细胞与淋巴细胞的比值作为接受一线化疗的转移去势抵抗性前列腺癌男性患者的预后生物标志物：两项随机III期试验的数据
2. Pretreatment neutrophil-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with ketoconazole: Association with outcome and predictive nomogram [J] . KeizmanD., GottfriedM., Ish-ShalomM., The oncologist . 2012,第12期

机译：酮康唑治疗转移性去势抵抗性前列腺癌患者的治疗前中性粒细胞与淋巴细胞比率：与预后和预测诺模图的关系
3. Pretreatment Neutrophil-to-Lymphocyte Ratio in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Ketoconazole: Association with Outcome and Predictive Nomogram [J] . Daniel Keizman, Maya Gottfried, Maya Ish-Shalom, The oncologist . 2012,第12期

机译：酮康唑治疗转移性去势抵抗的前列腺癌患者的治疗前中性粒细胞与淋巴细胞的比率：与结果和预测性诺法图的关系
4. Metastatic Hormone-Sensitive and Castration-Resistant Prostate Cancer: A Decade of Progress and Ongoing Discoveries [C] . Leonel Hernez-Aya, Maha Hussain Genitourinary Cancers Symposium. . 2014

机译：转移激素敏感和阉割的前列腺癌：进步和持续发现的十年
5. Development of novel biomarkers in cancer: Detection of circulating miR-141 as a potential prognostic marker for prostate cancer. [D] . Gonzales, Jason Cadaoas. 2010

机译：癌症中新型生物标志物的开发：检测循环miR-141作为前列腺癌的潜在预后标志物。
6. Pretreatment Neutrophil-to-Lymphocyte Ratio in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Ketoconazole: Association with Outcome and Predictive Nomogram [O] . Daniel Keizman, Maya Gottfried, Maya Ish-Shalom, 2012

机译：酮康唑治疗转移性去势抵抗的前列腺癌患者的治疗前中性粒细胞与淋巴细胞的比率：与结果和预测性诺法图的关系
7. Pretreatment biomarkers as prognostic predictors of survival in patients with Pancreatic Cancer treated with Gemcitabine-based Therapy and 5-Fluorouracil: Neutrophil-to-lymphocyte ratio vs Platelet-to-lymphocyte ratio [O] . Yungu Chen, Yuan Liao, Lek Man Lam, 2020

机译：预处理生物标志物作为牙科碱治疗胰腺癌和5氟尿嘧啶治疗的胰腺癌患者存活的预测预测因子：中性粒细胞对淋巴细胞比Vs血小板到淋巴细胞比率

Pretreatment neutrophil‐to‐lymphocyte ratio as a potential prognostic biomarker for newly diagnosed patients with metastatic castration‐sensitive prostate cancer

著录项

引文网络

相似文献

相关主题

期刊订阅